Exelixis reported an adjusted earnings beat of $0.91 per share for the second quarter. Revenue came in at approximately $628.7 million — below Wall Street consensus — and the stock fell
NEW YORK, Aug. 13, 2026 (GLOBE NEWSWIRE) — Shareholders of Exelixis, Inc. (NASDAQ: EXEL) watched the stock decline in after-hours trading following the Company’s second quarter results, in which adjusted earnings per share of $0.91 exceeded estimates while revenue of approximately $628.7 million came in below consensus. Investors who lost money on EXEL are encouraged to submit their information here. You may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.
Two numbers, one quarter. The adjusted profitability figure beat. The top-line sales figure missed. Coverage of the results from marketscreener.com stated that the primary catalyst for the decline “was a revenue miss relative to Wall Street expectations, despite an adjusted EPS beat.”
Levi & Korsinsky is investigating potential securities law violations concerning Exelixis, including whether the Company adequately conveyed to investors the state of its underlying sales performance.
Shareholders who purchased EXEL and suffered a loss may request a free case evaluation. You may also contact Joseph E. Levi, Esq. at [email protected] or (212) 363-7500.
Levi & Korsinsky, LLP — Top 50 securities litigation firm (ISS, seven consecutive years). Over 70 professionals. Hundreds of millions recovered.
Frequently Asked Questions About the EXEL Investigation
Q: Who is eligible to participate in the EXEL investigation? A: Investors who purchased EXEL stock or securities and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses — not on whether you still hold the shares.
Q: Which statements are being investigated? A: The investigation concerns whether Exelixis made materially false or misleading statements regarding its commercial performance and revenue trajectory. Second quarter revenue of approximately $628.7 million came in below consensus expectations, and the stock declined.
Q: Who is conducting the EXEL investigation? A: Levi & Korsinsky, LLP is investigating potential securities fraud claims on behalf of investors who purchased EXEL securities. The firm is nationally recognized and has recovered hundreds of millions of dollars for aggrieved investors.
Q: What do EXEL investors need to do right now? A: Gather brokerage records including purchase dates, share quantities, and prices paid. Contact Levi & Korsinsky for a free, no-obligation evaluation at [email protected] or (212) 363-7500.
Q: What documents do I need to participate? A: Brokerage statements or trade confirmations showing purchase dates, share quantities, prices paid, and any subsequent sale dates and prices.
Q: What if I already sold my EXEL shares — can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought EXEL and sold at a loss may still participate in the investigation.
Q: What does it cost me to participate? A: There is no upfront cost to participate. Securities investigations and any resulting actions are generally handled on a contingency basis — no retainer, no out-of-pocket costs.
Q: Do I need to go to court or give testimony? A: No. Participating in the investigation does not require court appearances or depositions.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
Attorney Advertising. Prior results do not guarantee similar outcomes.
